Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BXC
BXC logo

BXC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bluelinx Holdings Inc (BXC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
52.990
1 Day change
2.26%
52 Week Range
88.300
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Bluelinx Holdings Inc (BXC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed technical indicators, weak financial performance, and lacks significant positive catalysts. The absence of recent news, congress trading data, and proprietary trading signals further diminishes the case for immediate investment.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 54.306, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 52.916), suggesting limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the low trading volume limits the reliability of this data.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • The MACD indicates bullish momentum, and options data shows a bullish sentiment with a low put-call ratio.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025, with a significant drop in net income (-262.20% YoY) and EPS (-271.43% YoY). No recent news, congress trading data, or significant insider or hedge fund activity. Analysts have lowered the price target from $83 to $75.

Financial Performance

In Q4 2025, revenue increased slightly by 0.73% YoY to $715.8M, but net income dropped significantly to -$8.55M (-262.20% YoY), and EPS fell to -1.08 (-271.43% YoY). Gross margin also declined to 14.22% (-2.80% YoY), indicating deteriorating profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Benchmark lowered the price target from $83 to $75 while maintaining a Buy rating. This reflects reduced optimism about the stock's potential upside.

Wall Street analysts forecast BXC stock price to rise
2 Analyst Rating
Wall Street analysts forecast BXC stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 51.820
sliders
Low
68
Averages
71.5
High
75
Current: 51.820
sliders
Low
68
Averages
71.5
High
75
Benchmark
Buy
to
Buy
downgrade
$83 -> $75
AI Analysis
2026-02-27
Reason
Benchmark
Price Target
$83 -> $75
AI Analysis
2026-02-27
downgrade
Buy
to
Buy
Reason
Benchmark lowered the firm's price target on BlueLinx to $75 from $83 and keeps a Buy rating on the shares.
DA Davidson
Neutral
downgrade
$75 -> $68
2025-11-06
Reason
DA Davidson
Price Target
$75 -> $68
2025-11-06
downgrade
Neutral
Reason
DA Davidson lowered the firm's price target on BlueLinx to $68 from $75 and keeps a Neutral rating on the shares. The company's Q3 results were highlighted by encouraging Specialty volumes growth and flat pricing, though the firm is taking a more conservative stance around the 2026 demand environment and commodity pricing assumptions, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BXC
Unlock Now

People Also Watch